Korea S.E.
06:00:00 2024-05-30 pm EDT
5-day change
1st Jan Change
19,140
KRW
-0.31%
-2.00%
-11.39%
Tranche Update on Samjin Pharmaceuticals Co., Ltd.'s Equity Buyback Plan announced on December 2, 2022.
June 01, 2023 at 03:33 am EDT
From April 1, 2023 to June 1, 2023, the company has repurchased 0 shares, representing 0% for KRW 0 million. With this, the company has completed the repurchase of 183,020 shares, representing 1.36% for KRW 4,993.5 million under the buyback announced on December 2, 2022.
Neurophet, Inc. announced that it has received KRW 1 billion in funding from Samjin Pharmaceuticals Co., Ltd.
Feb. 28
CI
Tranche Update on Samjin Pharmaceuticals Co., Ltd.'s Equity Buyback Plan announced on June 16, 2023.
Dec. 15
CI
Tranche Update on Samjin Pharmaceuticals Co., Ltd.'s Equity Buyback Plan announced on June 16, 2023.
Dec. 15
CI
Samjin Pharmaceuticals Co., Ltd.'s Equity Buyback announced on June 16, 2023 has expired with 227,116 shares, representing 1.74% for KRW 4,996.59 million.
Dec. 14
CI
Tranche Update on Samjin Pharmaceuticals Co., Ltd.'s Equity Buyback Plan announced on March 24, 2023.
23-09-25
CI
Tranche Update on Samjin Pharmaceuticals Co., Ltd.'s Equity Buyback Plan announced on March 24, 2023.
23-09-25
CI
Samjin Pharmaceuticals Co., Ltd.'s Equity Buyback announced on March 24, 2023, has expired with 228,833 shares, representing 1.73% for KRW 4,995.92 million.
23-09-21
CI
Tranche Update on Samjin Pharmaceuticals Co., Ltd.'s Equity Buyback Plan announced on June 16, 2023.
23-09-18
CI
Tranche Update on Samjin Pharmaceuticals Co., Ltd.'s Equity Buyback Plan announced on March 24, 2023.
23-06-26
CI
Samjin Pharmaceuticals Co., Ltd. announces an Equity Buyback for KRW 5,000 million worth of its shares.
23-06-16
CI
Samjin Pharmaceuticals Co., Ltd. authorizes a Buyback Plan.
23-06-15
CI
Tranche Update on Samjin Pharmaceuticals Co., Ltd.'s Equity Buyback Plan announced on December 2, 2022.
23-06-01
CI
Tranche Update on Samjin Pharmaceuticals Co., Ltd.'s Equity Buyback Plan announced on December 2, 2022.
23-06-01
CI
Tranche Update on Samjin Pharmaceuticals Co., Ltd.'s Equity Buyback Plan announced on December 2, 2022.
23-06-01
CI
Samjin Pharmaceuticals Co., Ltd.'s Equity Buyback announced on December 2, 2022, has expired with 183,020 shares, representing 1.36% for KRW 4,993.50 million.
23-05-31
CI
Samjin Pharmaceuticals Co., Ltd. announces an Equity Buyback for KRW 5,000 million worth of its shares.
23-03-23
CI
Samjin Pharmaceuticals Co., Ltd. authorizes a Buyback Plan.
23-03-23
CI
Samjin Pharmaceuticals Co., Ltd. announces an Equity Buyback for KRW 5,000 million worth of its shares.
22-12-01
CI
Samjin Pharmaceuticals Co., Ltd. authorizes a Buyback Plan.
22-12-01
CI
AriBio Co., Ltd. agreed to acquire 7.99% stake in Samjin Pharmaceuticals Co., Ltd. for KRW 30 Billion.
22-08-29
CI
Tranche Update on Samjin Pharmaceuticals Co., Ltd.'s Equity Buyback Plan announced on June 7, 2017.
17-12-05
CI
Tranche Update on Samjin Pharmaceuticals Co., Ltd.'s Equity Buyback Plan announced on June 7, 2017.
17-12-05
CI
Samjin Pharmaceuticals Co., Ltd's Equity Buyback announced on June 7, 2017, has expired with 150,055 shares, representing 1.21% for KRW 4,939.97 million.
17-12-05
CI
Tranche Update on Samjin Pharmaceuticals Co., Ltd.'s Equity Buyback Plan announced on June 7, 2017.
17-09-07
CI
Samjin Pharmaceuticals Co., Ltd. announces an Equity Buyback for KRW 5,000 million worth of its shares.
17-06-06
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
Samjin Pharmaceuticals co., LTD. is a Korea-based company mainly engaged in the manufacture of pharmaceutical products. The Companyâs products include antipyretics, analgesics, antiphlogistic agents, osteoarthritis agents, osteopathic agents, antihistaminic agents, circulatory system drugs, gastrointestinal agents, osteoporosis treatments, hepatic disease agents, respiratory agents, antibiotics agents, detoxifying agents, antifungal agents, antineoplastic agents and others. Its products are provided in the forms of tablets, injections, capsules and others. It distributes its products to the hospitals and drugstores. The Company supplies its products within domestic market and to overseas markets.
More about the company
1st Jan change
Capi.
-11.39% 177M +15.91% 41.97B +22.40% 22.34B +18.48% 15.25B +16.12% 14B +45.12% 12.06B -0.05% 6.79B -9.58% 6.8B -8.87% 5.73B +14.18% 5.49B
Generic Pharmaceuticals
+951% of historical
More than 20 years
Our Experts
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1
SAMJIN PHARMACEUTICALS CO., LTD. 
